CEACAM5 and breast carcinoma: Cui et al. introduced a microfluidic biosensor that combined CA153, CA125, and CEA antibodies with DTNB, 4-mercaptobenzoic acid (4MBA), and 2-naphthalenthiol (2NAT)-labeled Ag nanomaterials to detect corresponding antigens for breast cancer diagnosis [92].